Neuromodulation Strategy
Strategy for VNS, taVNS, PNS, and advanced therapy companies entering the U.S. market.
USHSG supports neuromodulation and advanced therapy companies with clinical positioning, provider education strategy, research planning, access pathways, and commercialization support.
VNS and transcutaneous VNS market strategy
Peripheral nerve stimulation adoption support
Non-invasive stimulation clinical positioning
Provider education and clinical workflow mapping
Research scope development and outcome planning
Access strategy across clinical, wellness, and commercial channels
Build trust before scale
Move from innovation to trusted adoption.
US Health Strategy Group helps emerging healthcare companies structure the clinical, commercial, and advisory infrastructure needed for responsible growth.
Start a conversation